IsoPlexis to Participate in the Evercore ISI HealthCONx Conference

Rhea-AI Summary

IsoPlexis Corporation (Nasdaq: ISO), a leader in functional single-cell proteomics, will participate virtually in the Evercore ISI 4th Annual HealthCONx Conference on December 1 at 6:40 a.m. Pacific Time. A live and archived webcast of the management's fireside chat can be accessed on the company's website. IsoPlexis is recognized for its innovative approach to identifying proteomically active single cells, aiding researchers in developing precise therapies. Its platform is utilized by leading pharmaceutical companies and comprehensive cancer centers worldwide.

BRANFORD, Conn., Nov. 24, 2021 /PRNewswire/ -- IsoPlexis Corporation (Nasdaq: ISO), the leader in functional single-cell proteomics, today announced the company will be participating virtually in the upcoming Evercore ISI 4^th Annual HealthCONx Conference.

IsoPlexis' management is scheduled to participate in a fireside chat on Wednesday, December 1 at 6:40 a.m. Pacific Time / 9:40 a.m. Eastern Time. Interested parties may access a live and archived webcast on the "Investors" section of the company website at: www.isoplexis.com.

About IsoPlexis

IsoPlexis is leading a new era of functional proteomics. By identifying our most proteomically active single cells (or "superhero cells") for the first time, IsoPlexis enables researchers to connect more directly to in vivo biology and develop more precise and personalized therapies. IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies and at the majority of leading U.S. comprehensive cancer centers.

Investor Contact
investors@isoplexis.com

Press Contact
press@isoplexis.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/isoplexis-to-participate-in-the-evercore-isi-healthconx-conference-301431379.html

SOURCE IsoPlexis

FAQ

When is IsoPlexis participating in the Evercore ISI HealthCONx Conference?

IsoPlexis will participate in the Evercore ISI 4th Annual HealthCONx Conference on December 1, 2021, at 6:40 a.m. Pacific Time.

How can I access the IsoPlexis conference presentation?

The IsoPlexis conference presentation can be accessed via a live and archived webcast on the company's website under the 'Investors' section.

What is IsoPlexis known for?

IsoPlexis is known for leading advancements in functional single-cell proteomics and innovating in the identification of proteomically active single cells.

What companies use the IsoPlexis platform?

The IsoPlexis platform is used by researchers at the top 15 global pharmaceutical companies and many leading U.S. comprehensive cancer centers.

What innovations has IsoPlexis received recognition for?

IsoPlexis has been recognized for innovation by The Scientist Magazine, Fierce, BIG Innovation, Red Dot, and others.